Egea E, Iglesias A, Salazar M, Morimoto C, Kruskall M S, Awdeh Z, Schlossman S F, Alper C A, Yunis E J
Division of Immunogenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
J Exp Med. 1991 Mar 1;173(3):531-8. doi: 10.1084/jem.173.3.531.
We had previously obtained evidence that among normal subjects the humoral antibody response to hepatitis B surface antigen (HBsAg) was bimodally distributed with about 14% of subjects producing less than 1,000 estimated radioimmunoassay RIA units. From the study of major histocompatibility complex (MHC) markers in the very poor responders who produced less than 36 estimated RIA units of antibody, it appeared that there was an excess of homozygotes for two extended haplotypes [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7]. This finding suggested that a poor response was inherited as a recessive trait requiring nonresponse genes for HBsAg on both MHC haplotypes and was strengthened by finding a much lower antibody response among prospectively immunized homozygotes for [HLA-B8, SC01, DR3] compared with heterozygotes. In the present study, we have analyzed the cellular basis for nonresponse to this antigen by examining antigen-specific proliferation of T cells from responders and nonresponders in the presence and absence of autologous CD8+ (suppressor) cells. Peripheral blood cells from nonresponders to HBsAg failed to undergo a proliferative response to recombinant HBsAg in vitro, whereas cells from responders proliferated vigorously. This failure of cells from nonresponders to proliferate was not reversed in cell mixtures containing CD4+ and antigen-presenting cells devoid of CD8+ cells. There was no difference between responders and nonresponders with respect to the number of circulating T cells or their subsets, or the proliferative response to mitogens such as pokeweed or phytohemagglutinin or another antigen, tetanus toxoid. Our results indicate that our HBsAg nonresponding subjects have a very specific failure in antigen presentation or the stimulation of T helper cells, or both. Our evidence is against specific immune suppression as the basis for their nonresponsiveness. The failure of antigen presentation or T cell help is consistent with recessive inheritance of nonresponsiveness and suggests that response is dominantly inherited.
我们之前已获得证据,在正常受试者中,对乙肝表面抗原(HBsAg)的体液抗体反应呈双峰分布,约14%的受试者产生的放射免疫分析(RIA)单位估计少于1000。通过对产生少于36个估计RIA抗体单位的极低反应者的主要组织相容性复合体(MHC)标志物进行研究,发现两种扩展单倍型[HLA - B8,SC01,DR3]和[HLA - B44,FC31,DR7]的纯合子过多。这一发现表明,低反应作为隐性性状遗传,需要在两个MHC单倍型上都有针对HBsAg的无反应基因,并且通过发现与杂合子相比,[HLA - B8,SC01,DR3]的前瞻性免疫纯合子中的抗体反应低得多,这一观点得到了加强。在本研究中,我们通过检测有或无自体CD8 +(抑制性)细胞存在时,反应者和无反应者的T细胞对抗原的特异性增殖,分析了对该抗原无反应的细胞基础。乙肝表面抗原无反应者的外周血细胞在体外对重组乙肝表面抗原未产生增殖反应,而反应者的细胞则强烈增殖。在含有CD4 +细胞和不含CD8 +细胞的抗原呈递细胞的细胞混合物中,无反应者细胞的这种增殖失败并未得到逆转。反应者和无反应者在循环T细胞及其亚群的数量上,或对有丝分裂原如商陆或植物血凝素或另一种抗原破伤风类毒素的增殖反应方面没有差异。我们的结果表明,我们的乙肝表面抗原无反应受试者在抗原呈递或辅助性T细胞的刺激方面存在非常特异性的缺陷,或两者皆有。我们的证据表明,特异性免疫抑制不是其无反应性的基础。抗原呈递或T细胞辅助的失败与无反应性的隐性遗传一致,并表明反应是显性遗传。